enGene enters $100M ATM equity sale agreement with Jefferies

enGene Therapeutics Inc.

Entered Open Market Sale Agreement with Jefferies for ATM offering of common shares up to $100M.
Jefferies receives up to 3% commission; shares sold under prospectus supplement dated Dec 20, 2024.
Offering not available in Canada and company not obligated to sell any shares.
Agreement terminable by either party; proceeds for general corporate purposes not specified.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.